Jeff S. Isenberg - Concepedia

Author

Jeff S. Isenberg

Also Known As

J S Isenberg, J. S. Isenberg, J. Scott Isenberg, J.S. Isenberg, J.Scott Isenberg, JEFFREY ISENBERG, Jeff Isenberg, Jeff S Isenberg, Jeff S. Isenberg

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Cancer Institute Center for Cancer Research Washington University in St. Louis University of Pittsburgh

About

Jeff S. Isenberg is an author at National Institutes of Health specializing in medicine, vascular biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.8K
2	Health Sciences	2	2	161
3	Engineering	1	1	18
4	Natural Sciences	1	1	50
5	Biochemistry	1	1	50

Jeff S. Isenberg

Publications

Citations

H-Index

Page 1

	Year	Citations
CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1 Jeff S. Isenberg, Lisa A. Ridnour, Julie Dimitry, Journal of Biological Chemistry	2006	279
Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner Jeff S. Isenberg, Lisa A. Ridnour, Elizabeth M. Perruccio, Proceedings of the National Academy of Sciences Nitric OxideImmunologyCgmp-dependent MannerInflammationThrombosis	2005	269
Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47 Sukhbir Kaur, Gema Martin‐Manso, Michael L. Pendrak, Journal of Biological Chemistry ImmunologyInflammationThrombosisAngiogenesisCd47 Expression	2010	221
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling Jeff S. Isenberg, Martin J. Romeo, Christine Yu, Blood	2007	197
Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling Justin B. Maxhimer, David R. Soto‐Pantoja, Lisa A. Ridnour, Science Translational Medicine ImmunologyImmunotherapyTumor BiologyOncologyDelayed Tumor Growth	2009	179
Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation Eileen Bauer, Qin Yan, Thomas W. Miller, Cardiovascular Research	2010	147
Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses Jeff S. Isenberg, Douglas S. Annis, Michael L. Pendrak, Journal of Biological Chemistry ImmunologyCell DeathCellular PhysiologyInflammationThrombosis	2008	146
Thrombospondin-1 Inhibits Nitric Oxide Signaling via CD36 by Inhibiting Myristic Acid Uptake Jeff S. Isenberg, Yifeng Jia, Julia Fukuyama, Journal of Biological Chemistry Myristate UptakeCgmp SynthesisImmunologyCell DeathCellular Physiology	2007	134
Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide–mediated vascular smooth muscle relaxation Jeff S. Isenberg, Fuminori Hyodo, Martin J. Romeo, Blood	2006	123
Increasing Survival of Ischemic Tissue by Targeting CD47 Jeff S. Isenberg, Martin J. Romeo, Mones Abu‐Asab, Circulation Research Cell TherapyImmunologyCell DeathCell Replacement TherapyBiomedical Engineering	2007	119

Page 1